Adjuvant therapy in pancreatic cancer: historical and current perspectives. - Wikidata - wikimedia - TriplyDB

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

http://www.wikidata.org/entity/Q35110205

about

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma.B7-H3 overexpression in pancreatic cancer promotes tumor progression.Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer.Biology and management of pancreatic cancer.Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.Review article: chemotherapy for pancreatic cancer.Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer.RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells.Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer Determination of factors predictive of outcome for patients undergoing a pancreaticoduodenectomy of pancreatic head ductal adenocarcinomas.The role of preoperative biopsy in pancreatic cancer Late complication in patients undergoing pancreatic resection with intraoperative radiation therapy: gastrointestinal bleeding with occlusion of the portal system.Hypoxia and angiogenesis in pancreatic cancer.Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials.Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer.Medical treatment of pancreatic cancer.Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.Excess premature (3-month) mortality in advanced pancreatic cancer could be related to fatal vascular thromboembolic events. A hypothesis based on a systematic review of phase III chemotherapy studies in advanced pancreatic cancer.The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer.FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity.Integrinβ1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomas.Oridonin inhibits BxPC-3 cell growth through cell apoptosis.Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum.Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.Characterization of Pancreatic Cancer Cell Thermal Response to Heat Ablation or Cryoablation Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro.RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells.Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells.Interferon receptor alpha/beta is associated with improved survival after adjuvant therapy in resected pancreatic cancer.Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma.Adjuvant systemic chemotherapy with gemcitabine for stage IV pancreatic cancer: a preliminary report of initial experience.

P2860

Q24811656-16A76D5F-046F-41FB-AEE8-972EE043DEF3 Q28074614-84F054D6-3C6B-46D3-9EBA-590B70E34114 Q33367266-149CBCBE-ED24-478D-BD95-5CB90D2DBCB2 Q33703916-37B40234-01A7-41D7-BF40-528CD577A434 Q34493969-784DAD57-4E1D-4CAB-B692-1BBD27995E7E Q34649019-DF1038DA-497B-4E30-945C-AEC8E76AD7E6 Q35064866-31426681-1EB1-4C37-8A13-419EFA92C29A Q35599597-A09A6F9C-BE6E-4D1D-8042-1CA86905ED35 Q35760402-B8EE4A0E-DB92-43C4-8097-A736B800E997 Q35840236-689A9803-9394-4E46-961D-556992C63B2B Q35843107-F0F31CBF-2383-4519-9ED9-0EA115DD57C8 Q35886662-D484356F-BF1C-4A5B-805D-526774B2DC6E Q36014277-979C7B16-A025-4DC8-A7C4-9CA410FA96FB Q36063267-0D88F8BF-8A4D-4ACB-89E8-F891FA27DA75 Q36063347-12FCE7DC-061A-495C-8CE1-E727AD358CE5 Q36209760-BCD98AFE-D854-486A-935C-804471E0BAF6 Q36572752-4471CADC-1353-464A-87AA-E69B1A6F9224 Q36614087-0A922CBB-2154-49DA-91B2-8681064D4BEF Q36615091-A953B813-C048-4ED9-AA26-C35A52972C20 Q36616676-BD87C746-BC8E-4074-9B6A-192CB8FAE7BF Q36695742-0C04DB0B-D31C-4EF1-8871-D6F054DB0413 Q36788494-D42683BA-F96A-4300-BD70-F2F7A1CD08E5 Q36886874-F2CDB453-682D-439E-A5A1-BA49F34B28F4 Q36980432-593C29C3-FEC9-4AFE-A33A-136000134221 Q37134542-D0B3E6C0-B0FB-47DF-B136-CE139FA956F9 Q37716906-2B00F4CA-15CA-48CE-AF65-8835B4CF85AA Q38662233-E60475F8-1C86-405D-997D-84732DC96D72 Q38737031-B9039C7F-8C6F-40ED-BDDA-D524CF2E3580 Q38912986-EE4D9819-B6CF-4572-AA77-235401158706 Q39390859-FAD05915-704B-49CC-9EF7-2438D76CE746 Q39447548-B48025D5-C016-49E1-8E9A-8608543C249C Q39589062-A5480399-E604-4478-B59D-491ADC26259A Q39657970-D184E4F4-8618-453C-BE8C-84B99CF44402 Q39702637-352AC3BF-7D7F-4CCA-91EB-FBF9EE180391 Q40141198-46762141-542F-4237-8ACE-B2FD9EE127D7 Q42108466-C4B1941B-B1C6-4BEA-BE82-7DEE99E92DC7 Q42142077-32510939-948D-4D4D-A2F6-8CE0697D0327 Q43686477-5C32B36C-7549-461F-B65C-AAB833802B0B Q46553130-59A2F214-AA58-4807-8F23-E8E89FCC4895 Q46752225-C0524F29-8575-49DF-AA45-7EF2C4670D7A

P2860

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

http://www.wikidata.org/entity/Q35110205

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

@ast

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

@en

type

label

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

@ast

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

@en

prefLabel

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

@ast

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

@en

P1433

Q35110205-C9986BD2-990D-44DE-999E-AB957895AAD2

P1476

Q35110205-6A929D4C-7BFC-496C-9FA1-6BA41CB08BDA

P2093

Q35110205-05CEC1E5-E039-4D77-9EC7-A3FBB8669BF0

Q35110205-219C2E29-C43F-4C69-9FC5-FDF538D6AD59

Q35110205-2363F330-D76C-4704-9339-3B09F1F158EC

Q35110205-2960C1F8-7C5F-447D-82BF-390C9FC0D5B8

Q35110205-3C025057-B309-4C1D-B3F4-64B4457DEAFB

Q35110205-4EA6C0BC-488C-443F-BC16-F9481F9575DD

Q35110205-60473833-9ACB-4230-9FA2-F3C4F6E523CD

Q35110205-77EC1F27-452F-4A19-BAD7-B1D18244D24F

Q35110205-8ACA89E8-9AB2-42C5-A97D-BB1EC354AAEF

Q35110205-B2D56F2D-3802-4BFC-AE86-3FE952CD7811

P304

Q35110205-37399A12-8B44-4B36-AF4E-88CE200979C4

P31

Q35110205-2B3FE33E-76DC-46BB-A500-6040856A5CA6

P356

Q35110205-39D52C1F-2DAE-4360-804F-E1546D96650D

P433

Q35110205-62A6B55A-53F7-4F87-8713-8E2153B9D084

P478

Q35110205-6B956811-CC95-47C0-8ACF-5475C5581F01

P50

Q35110205-973E60A2-0811-4431-8787-841033915217

Q35110205-EB68B296-1F9B-4F91-8452-3FFC0A752BAE

P577

Q35110205-CB497BEB-CE27-472E-BEFF-9FCA2E79C8D0

P5875

Q35110205-1E24CF9C-0E2F-4A02-A34F-C03277BE88F6

P698

Q35110205-5C3BF1F4-930F-408F-B3A2-1DA190EB4F8B

P356

P1433

Annals of Oncology

P1476

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

@en

P2093

C Bassi

http://www.w3.org/2001/XMLSchema#string

C Dervenis

http://www.w3.org/2001/XMLSchema#string

D D Stocken

http://www.w3.org/2001/XMLSchema#string

D M Tait

http://www.w3.org/2001/XMLSchema#string

F Lacaine

http://www.w3.org/2001/XMLSchema#string

H Friess

http://www.w3.org/2001/XMLSchema#string

H Hickey

http://www.w3.org/2001/XMLSchema#string

J A Dunn

http://www.w3.org/2001/XMLSchema#string

J P Neoptolemos

http://www.w3.org/2001/XMLSchema#string

M G T Raraty

http://www.w3.org/2001/XMLSchema#string

P304

675-692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDG207

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

David Cunningham

Markus Büchler

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10797525

http://www.w3.org/2001/XMLSchema#string

P698

12702520

http://www.w3.org/2001/XMLSchema#string